1783134-96-2
Chemical Structure
HIF-IN-3
- CAS No.: 1783134-96-2
- Formula:C20H26N4O2
- Molecular Weight:354.45
InChIKey: XBZDBEBKMLRLOK-CALCHBBNSA-N
SMILES: O[C@@H]1C[C@H](C2=NC=NC(N3CCN(CC3)CCOC4=CC=CC=C4)=C2)C1
Biological Activity: HIF-IN-3 is a HIF inhibitor. HIF-IN-3 blocks the dimerization of HIF-α with HIF-1β by binding to the PAS domain of HIF-α, and induces the degradation of HIF-1α and HIF-2α via the ubiquitin-proteasome pathway. HIF-IN-3 inhibits the expression of the endogenous HIF-1 target gene CA9 and the HIF-2 target gene EPO in cancer cells. HIF-IN-3 inhibits tumor growth in the BT-474 breast cancer model. HIF-IN-3 can be used for research on HIF-related tumors such as breast cancer, colorectal cancer, and head and neck squamous cell carcinoma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HIF-IN-3 | HIF-IN-3 is a HIF inhibitor. HIF-IN-3 blocks the dimerization of HIF-α with HIF-1β by binding to the PAS domain of HIF-α, and induces the degradation of HIF-1α and HIF-2α via the ubiquitin-proteasome pathway. HIF-IN-3 inhibits the expression of the endogenous HIF-1 target gene CA9 and the HIF-2 target gene EPO in cancer cells. HIF-IN-3 inhibits tumor growth in the BT-474 breast cancer model. HIF-IN-3 can be used for research on HIF-related tumors such as breast cancer, colorectal cancer, and head and neck squamous cell carcinoma. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
